Harold Keer

Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer

New England Journal of Medicine · 1995 · 1,019 citations

Phase II study evaluating 2 dosing schedules of oral foretinib (GSK1363089), cMET/VEGFR2 inhibitor, in patients with metastatic gastric cancer

PLoS ONE · 2013 · 176 citations